A chemistry—medicine collaboration has given rise to a new nanotechnology that holds promise for personalized cancer vaccines. Personalized cancer vaccines may be one step closer to reality following new multidisciplinary research from the Lin (chemistry) and Weichselbaum (medicine) labs at the University of Chicago (IL, USA). The researchers developed a two-pronged approach using nanoscale metal-organic frameworks (nMOFs) that aim to provide both local and systemic treatment in one therapeutic and activate both the innate and adaptive immune response. nMOFs comprise repeating units in a lattice formation, which makes them ideal for delivering anti-cancer drugs. They also generate free radicals within...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!